… Valganciclovir (VGCV) is a prodrug of GCV with improved … treatment to oral GCV w7x for
treatment of neonates. We present a neonate with congenital CMV infection, who was treated …

… , valganciclovir appears to have some advantages over ganciclovir. Therefore, when used as
prophylaxis against CMV infection … of CMV retinitis in patients with AIDS, oral valganciclovir …

… review, the presently established treatment approaches for CMV infection and disease in …
for valganciclovir use; in the second part of the article, data on valganciclovir generated from …

… ) in high-risk transplant recipients and for the treatment of CMV retinitis in AIDS patients.
We used VGC for the treatment of CMV infection (viremia without symptoms) or disease (CMV …

… as prophylaxis in bone marrow or lung transplant recipients, or using valganciclovir as
treatment for active CMV infection in solid organ transplant recipients. In addition, although there …

… management of cytomegalovirus infection in the immunocompromised host. Valganciclovir
… The administration of 900 mg of valganciclovir orally is comparable to a dose of intravenous …

… -controlled trial of valganciclovir therapy in neonates with symptomatic congenital CMV
disease, … Although congenital CMV infection is rare overall, it accounts for 21% of children with …

… In our current study, we evaluated the use of oral valganciclovir for treating anterior segment
inflammation caused by CMV infection, and all patients had a minimum follow-up period of …

… The main side effect of treatment was transient neutropenia. In conclusion, prolonged …
congenital CMV infection with intravenous ganciclovir followed by oral valganciclovir is safe, and it …

… of localized CMV infection (CMV inclusion cells or in situ detection of … with CMV disease,
oral valganciclovir has comparable safety and is not inferior to standard iv ganciclovir treatment …